TAROCCHI, MIRKO
 Distribuzione geografica
Continente #
NA - Nord America 3.060
EU - Europa 2.095
AS - Asia 471
SA - Sud America 3
AF - Africa 1
OC - Oceania 1
Totale 5.631
Nazione #
US - Stati Uniti d'America 3.057
PL - Polonia 886
IE - Irlanda 348
IT - Italia 295
SE - Svezia 252
HK - Hong Kong 152
CN - Cina 113
SG - Singapore 75
DE - Germania 71
JO - Giordania 60
RU - Federazione Russa 59
FI - Finlandia 47
GB - Regno Unito 39
UA - Ucraina 29
VN - Vietnam 27
CH - Svizzera 26
IN - India 24
ES - Italia 12
KR - Corea 11
BE - Belgio 10
NL - Olanda 8
FR - Francia 7
TW - Taiwan 4
BR - Brasile 3
RO - Romania 3
TR - Turchia 3
AT - Austria 2
CA - Canada 2
ID - Indonesia 2
AU - Australia 1
BB - Barbados 1
EG - Egitto 1
LI - Liechtenstein 1
Totale 5.631
Città #
Warsaw 886
Fairfield 508
Dublin 347
Ashburn 273
Chandler 248
Woodbridge 248
Seattle 205
Cambridge 192
Houston 192
Wilmington 176
Lawrence 119
Altamura 117
Ann Arbor 111
Hong Kong 92
Princeton 86
Florence 65
Beijing 59
Boston 51
Boardman 48
Jacksonville 42
Singapore 42
Medford 39
Shanghai 33
Bremen 31
Buffalo 30
Moscow 27
San Diego 27
Falls Church 26
Bern 24
Dong Ket 22
Pune 19
Kent 18
Norwalk 17
New York 16
Hillsboro 13
Barcelona 12
Brussels 10
Seoul 9
Andover 7
El Monte 6
Hanover 6
London 5
Milan 5
Phoenix 5
Cagliari 4
Guangzhou 4
Hangzhou 4
Redwood City 4
Rome 4
Taichung 4
Washington 4
Central 3
Dearborn 3
Izmir 3
San Giovanni Valdarno 3
Tappahannock 3
Cedar Knolls 2
Chengdu 2
Chiswick 2
Concorezzo 2
Deruta 2
Laurel 2
Leawood 2
Los Angeles 2
Naaldwijk 2
New Delhi 2
Nürnberg 2
Ottawa 2
Saint-Fons 2
San Lazzaro di Savena 2
Scandicci 2
Suwon 2
São Paulo 2
Wanchai 2
West Jordan 2
Abbadia 1
Acton 1
Anaheim 1
Antony 1
Auburn Hills 1
Bagneux 1
Bethesda 1
Bhubaneswar 1
Bologna 1
Caldogno 1
Campi Bisenzio 1
Cecina 1
Chennai 1
Corciano 1
Edinburgh 1
Erchie 1
Esslingen am Neckar 1
Fiesole 1
Fiumicino 1
Fontebuona 1
Fremont 1
Garbagna Novarese 1
Gateshead 1
Genoa 1
Grevenbroich 1
Totale 4.620
Nome #
Effect of a counseling-supported treatment with the Mediterranean diet and physical activity on the severity of the non-alcoholic fatty liver disease 244
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways 218
Exocycilic DNA Adducts in a Murine Model of Non-alcoholic Steatohepatitis 178
PPARγ and Oxidative Stress: Con(β) Catenating NRF2 and FOXO. 177
An Unexpected Hepatocellular Carcinoma arising From an Unknown Nonalcoholic Fatty liver 168
Nuclear orphan receptor COUP-TF2 induces anoikis resistance, amoeboid migration and metastatic potential in hepatocellular carcinoma (HCC) 147
Chemotherapy for hepatocellular carcinoma: The present and the future 141
A new regulator of mitochondrial OXPHOS in hepatocytes and HCC cell lines: the AAA plus ATPase RuvBL1 128
COUP-TFII in pancreatic adenocarcinoma: Clinical implication for patient survival and tumor progression. 123
Peroxisome proliferator activated receptors at the crossroad of obesity, diabetes, and pancreatic cancer 120
Antidiabetic thiazolidinediones induce ductal differentiation but not apoptosis in pancreatic cancer cells. 111
The orphan nuclear receptor COUP-TFII coordinates hypoxia-independent proangiogenic responses in hepatic stellate cells 105
Gastric and duodenal polyps in familial adenomatous polyposis patients: Conventional endoscopy vs virtual chromoendoscopy (fujinon intelligent color enhancement) in dysplasia evaluation 105
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score 102
Effects of the Olive-Derived Polyphenol Oleuropein on Human Health. 101
Functional Linkage of Cirrhosis-Predictive Single Nucleotide Polymorphisms of Toll-like Receptor 4 to Hepatic Stellate Cell Responses 99
Antidiabetic thiazolidinediones inhibit hepatic tumor formation in HBV transgenic mouse model. 96
Mitotic Checkpoint CHK2 Upregulation is Linked to Chromosomal Instability in Human Hepatocellular Carcinoma 94
Stevens-Johnson Syndrome and Herpes Simplex Type 1 Infection during Adalimumab Therapy for Crohn's Disease 92
Telomerase activated thymidine analogue pro-drug is a new molecule targeting hepatocellular carcinoma 87
How to define hypogonadism? Results from a population of men consulting for sexual dysfunction 83
Hepatocyte-specific deletion of RuvBL1 leads to chronic liver damage and regeneration, enhancing HCC development 83
Environmental Pollution: A Tangible Risk for NAFLD Pathogenesis 82
Important Role of Sirt1 In the Survival and Activation of Hepatic Stellate Cells During Liver Injury 81
Pathway-based analysis of primary biliary cirrhosis genome-wide association studies. 78
Increased Risk of Liver Cirrhosis during Azathioprine Therapy for Crohn's Disease 78
"Liver Pathophysiology" - 1st edition 76
Thiazolidinediones inhibit growth and invasiveness of the human adrenocortical cancer cell line H295R 75
Increased Risk of Hepatocellular Carcinoma in Patient with Inflammatory Bowel Disease and Hemochromatosis: A Case Report 74
Small bowel lymphangioma: A rare case of intestinal bleeding 72
P0244 : Thieno-triazolodiazepines block hepatocarcinoma progression by HSP-dependent kinoma inhibition 72
Carcinogen-Induced Hepatic Tumors in KLF6+/- Mice Recapitulate Aggressive Human Hepatocellular Carcinoma Associated with p53 Pathway Deregulation 72
Acetaldehyde inhibits PPARgamma via H2O2-mediated c-Abl activation in human hepatic stellate cells. 71
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 70
Ruvbl1 regulates liver glucose metabolism via the Akt/mTOR pathway: Implications for hepatocellular carcinoma progression 69
Molecular mechanism of hepatitis B virus-induced hepatocarcinogenesis 67
Nuclear receptors and pathogenesis of pancreatic cancer 67
Telomerase Activated Thymidine Analogue Pro-drug Is A New Molecule Targeting Hepatocellular Carcinoma 65
Ras promotes growth by alternative splicing-mediated inactivation of the KLF6 tumor suppressor in hepatocellular carcinoma 65
Liver haploinsufficiency of RuvBL1 causes hepatic insulin resistance and enhances hepatocellular carcinoma progression 64
In vivo regulation of p21 by the Kruppel-like factor 6 tumor-suppressor gene in mouse liver and human hepatocellular carcinoma 63
Effects of Probiotics Administration on Human Metabolic Phenotype 63
Loss of hepatic RuvBL1 accelerates DEN-induced carcinogenesis due to chronic liver damage and regeneration 62
Thiazolidinediones inhibit hepatocarcinogenesis in hepatitis B virus-transgenic mice by peroxisome proliferator-activated receptor gamma-independent regulation of nucleophosmin. 62
Acetaldehyde induced collagen synthesis by inhibition of PPARgamma trascriptional activity via hydrogen peroxide-mediated activation of c-Abl non-receptor tyrosine kinase in human hepatic stellate cells 60
THU-449-Nuclear orphan receptor COUP-TF2 increases the resistence to anoikis and induces amoeboid movment and metastatic potential in hepatocellular carcinoma 60
Vascular injury triggers krüppel-like factor 6 (KLF6) mobilization and cooperation with Sp1 to promote endothelial activation through upregulation of the activin receptor-like kinase 1 (ALK1) gene 58
Effects of the "lete" bicarbonate - Calcic water administration in functional dyspepsia [Effetti della somministrazione di acqua minerale bicarbonato calcica "lete" nella dispepsia funzionale] 57
Peroxisome proliferator-activated receptor gamma agonist pioglitazone reduces the development of necrotizing enterocolitis in a neonatal preterm rat model 57
Oxidative DNA damage and formalin-fixation procedures 54
A N-TRUNCATED ISOFORM OF THE ORPHAN NUCLEAR RECEPTOR COUP-TFII MODULATES PANCREATIC CANCER PROGRESSION 51
Oxydative stress stimulates proliferation and invasiveness of hepatic stellate cells via a MMP2-mediated mechanism 45
Telomerase reactivation is associated with hepatobiliary and pancreatic cancers 44
CHRONIC PARTICULATE MATTER EXPOSITION REPRESENTS A SECOND HIT IN THE PROGRESSION FROM STEATOSIS TO STEATOHEPATITIS 41
Loss of Hepatic RuvBL1 Causes Chronic Liver Damage and Regeneration, Promoting Hepatocellular Carcinoma 41
Resection of NAFLD-Associated HCC: Patient Selection and Reported Outcomes 41
Pontin52 Is A Ppargamma Target Gene and Its Knockdown Reduces Hepatic Cancer In An Orthotopic-singenic Mouse Model 41
null 39
Reduced Klf6 Expression Correlates With Poor Prognosis In Human Hepatocellular Carcinoma (hcc) and Enhanced Chemical Carcinogenesis In Klf6+/- Mice 39
A MITOCHONDRIAL ROLE FOR THE CANCER-RELATED AAA plus ATP-ASE RUVBL1 38
Ligation-mediated polymerase chain reaction detection of 8-oxo-7,8-dihydro-2′-deoxyguanosine and 5-hydroxycytosine at the codon 176 of the p53 gene of hepatitis c-associated hepatocellular carcinoma patients 38
The orphan receptor COUP-TF II (Arp-1) is required for stellate cells activation and is involved in mitogenic responses in activated cells. 36
Role of Kruppler-like factor 6 in the hepatocellular carcinoma development 35
Rosiglitazone reduces the in vitro and in vivo growth of HCC cell lines through a PPARgamma-independent inhibition of Ruvbl-1 35
Therapeutic effects of a telomerase activated pro-drug, acycloguanosyl 5 '-thymidyltriphosphate, in hepatocellular carcinoma 35
Klf6 Deficiency Promotes Hepatocellular Carcinoma In Mice and Humans By Increasing Mdm2 Expression and Accelerating P53 Degradation 33
THIENO-TRIAZOLODIAZEPINES BLOCK HEPATOCARCINOMA PROGRESSION BY HSP-DEPENDENT KINOMA INHIBITION 33
THIAZOLIDINEDIONES INHIBIT HEPATIC TUMOUR FORMATION IN HBV TRANSGENIC MICE BY A PPAR gamma-INDEPENDENT REGULATION OF NUCLEOPHOSMIN 32
Isoforms of the orphan nuclear receptor COUP-TFII differentially modulate pancreatic cancer progression 31
Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055)) 31
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 30
Uno sguardo ai consumi alimentari nel territorio toscano: valutazione dell’impatto sulla “dimensione salute” 29
Malattie dell'apparato digerente. Edizione 2019-2022. Con Contenuto digitale per accesso on line 27
Oxidative Stress as a Mechanism for Hepatocellular Carcinoma 26
Infectious risk of vedolizumab compared with other biological agents in the treatment of inflammatory bowel disease 26
Oxidative stress induce collagen synthesis by c-Abl activation in human hepatic stellate cells 25
SIRT1 ACTIVATION PREVENTS APOPTOSIS AND SENESCENCE OF HEPATIC STELLATE CELL DURING LIVER INJURY 25
ANTAGONISTIC SIGNALLING BY PPARGAMMA AND ROSIGLITAZONE CONVERGE ON RUVBL1 REGULATION IN HCC CELLS 22
Role of Sex Hormones in Prevalent Kidney Diseases 18
Needs evaluation questionnaire for liver disease: a novel assessment of unmet needs in patients with chronic liver disease 15
Telomerase Activated Thymidine Analogue Prod-drug Prevents Growth and Induces Regression In Two In Vivo Models of Hepatocellular Carcinoma 12
T.03.4 SPHINGOSINES, COUP-TFII AND PANCREATIC CANCER 9
Totale 5.719
Categoria #
all - tutte 19.297
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.297


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.208 85 87 23 85 146 145 134 144 129 93 115 22
2020/2021838 73 90 57 97 44 79 43 63 76 121 47 48
2021/2022548 20 39 41 37 19 31 18 47 31 34 73 158
2022/20231.464 128 321 83 96 84 242 191 77 160 8 40 34
2023/2024616 20 60 84 23 35 122 20 133 16 19 44 40
2024/2025106 106 0 0 0 0 0 0 0 0 0 0 0
Totale 5.719